Effectiveness of ciclesonide versus budesonide in patients with asthma (18 to 75 y) (BY9010/M1-136)

Study identifier:BY9010/M1-136

ClinicalTrials.gov identifier:NCT00163384

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A comparative study of inhaled ciclesonide 160 mcg/day vs budesonide 400 mcg/day in patients with asthma

Medical condition

asthma

Phase

Phase 3

Healthy volunteers

No

Study drug

Ciclesonide

Sex

All

Actual Enrollment

240

Study type

Interventional

Age

18 Years - 75 Years

Date

Study Start Date: 01 Jan 2004
Primary Completion Date: 01 May 2005
Study Completion Date: 01 May 2005

Study design

Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind
Primary Purpose: Treatment

Verification:

Verified 01 Oct 2016 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria